|
ST13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.99549999991522E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.692500E-02 |
| Normal-vs-Stage2 |
2.324500E-02 |
| Normal-vs-Stage3 |
1.57156999999186E-05 |
| Normal-vs-Stage4 |
5.08199999971204E-07 |
| Stage1-vs-Stage2 |
2.405200E-01 |
| Stage1-vs-Stage3 |
2.601100E-03 |
| Stage1-vs-Stage4 |
2.150000E-04 |
| Stage2-vs-Stage3 |
2.598400E-01 |
| Stage2-vs-Stage4 |
6.362100E-02 |
| Stage3-vs-Stage4 |
3.967800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75360000000047E-05 |
| Normal-vs-AfricanAmerican |
5.94139959453344E-10 |
| Normal-vs-Asian |
7.064100E-02 |
| Caucasian-vs-AfricanAmerican |
1.399000E-04 |
| Caucasian-vs-Asian |
3.986600E-01 |
| AfricanAmerican-vs-Asian |
7.023800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.42570000045184E-07 |
| Normal-vs-Female |
2.022100E-03 |
| Male-vs-Female |
2.475600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.219900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.636200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.77890000002878E-06 |
| Normal-vs-Age(81-100Yrs) |
2.250400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.834030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.566400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.289000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.369000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.010000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.807600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.590800E-01 |
| Normal-vs-Grade 2 |
1.048210E-01 |
| Normal-vs-Grade 3 |
1.63974999999317E-05 |
| Normal-vs-Grade 4 |
3.37510019932097E-11 |
| Grade 1-vs-Grade 2 |
7.221600E-01 |
| Grade 1-vs-Grade 3 |
5.282300E-02 |
| Grade 1-vs-Grade 4 |
4.08840000000188E-05 |
| Grade 2-vs-Grade 3 |
5.137800E-03 |
| Grade 2-vs-Grade 4 |
1.03859998379363E-09 |
| Grade 3-vs-Grade 4 |
1.200520E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.519700E-02 |
| Normal-vs-ccB subtype |
8.3322237998118E-13 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.02349999999641E-05 |
| Normal-vs-N1 |
1.704450E-03 |
| N0-vs-N1 |
2.293900E-02 |
|
|
